2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Page 2 of 19 4.2 Dose and method of administration PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) EMEND (aprepitant) is available as capsules for oral administration.
Download 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
EMPIRIC GUIDELINES FOR TREATMENT OF CYCLIC …
www.cvsa.org.ukMAY, 2005 EMPIRIC GUIDELINES FOR THE MANAGEMENT OF CYCLIC VOMITING SYNDROME There is as yet, no standard, evidence-based treatment regimen for CVS. Management must be individualized and “fine-tuned” …
Get to Know an Enzyme: CYP3A4 - Hansten and Horn
www.hanstenandhorn.comAlfentanil (Alfenta) Alfuzosin (Uroxatral) Almotriptan (Axert) Alprazolam (Xanax) Amiodarone (Cordarone) Amlodipine (Norvasc) Aprepitant (Emend) Atazanavir (Reyataz)
Patient Information EMEND (EE mend) (aprepitant) …
www.merck.comPatient Information EMEND® (EE mend) (aprepitant) capsules EMEND® (EE mend) (aprepitant) for oral suspension Read this Patient Information before you start taking EMEND and each time you get a refill.
DRUG NAME DRUG NAME - Southern Scripts, LLC
www.southernscripts.netSpecialty Drug List 2 *LDD-Limited distribution drug that must be filled at a specified pharmacy. ver10262017 DRUG NAME DRUG NAME BeneFIX KIT
化療止吐藥 Aprepitant ( Emend 介紹 化療止吐藥 …
wwwu.tsgh.ndmctsgh.edu.tw三總藥訊96.11 5 Neurokinin-1 receptor antagonist 與5- HT 3 recepteor antagonist 比較表 學名 Aprepitant Granisetron Ondansetron 商品名 Emend …
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.merck.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EMENDCAPSULES and EMEND …
The Merck Access Program Enrollment Form
www.merckaccessprogram.com1/17 The Merck Access Program Enrollment Form Phone: 855-257-3932, Fax: 855-755-0518 The Merck Access Program PO Box 29067 Phoenix, AZ 85038 To geT sTarTed, compleTe The enrollmenT form and fax iT To 855-755-0518.
The Merck Access Program Enrollment Form
www.merckaccessprogram.com1/6 The Merck Access Program Enrollment Form TO GET STARTED, COMPLETE THE ENROLLMENT FORM AND FAX IT TO 855-755 …